CD38 and Miyoshi myopathy: The cells showed strong toxic effects against CD38+ MM cell lines (LP-1, RPMI 8226, OPM2, MOLP8, and primary MM cells from patients) and inhibited tumor growth in mice inoculated with RPMI 8226 cells [164].